Zobrazeno 1 - 10
of 1 817
pro vyhledávání: '"Scott A. Fisher"'
Autor:
Elly Marcq, Anna K Nowak, W Joost Lesterhuis, Caitlin M Tilsed, Nicola Principe, Amber-Lee Phung, Kofi L P Stevens, Omar Elaskalani, Ben Wylie, Fezaan Sheikh, M Lizeth Orozco Morales, Joel Kidman, Scott A Fisher, Alison M McDonnell, Jonathan Chee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 9 (2024)
Background Antibodies that target immune checkpoints such as cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein/ligand 1 (PD-1/PD-L1) are approved for treatment of multiple cancer types. Chemotherapy is often administered with i
Externí odkaz:
https://doaj.org/article/7f07a0c5e8004791ac4fe2312e89506b
Autor:
Caitlin M. Tilsed, M. Lizeth Orozco Morales, Rachael M. Zemek, Brianna A. Gordon, Matthew J. Piggott, Anna K. Nowak, Scott A. Fisher, Richard A. Lake, W. Joost Lesterhuis
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Chemotherapy is included in treatment regimens for many solid cancers, but when administered as a single agent it is rarely curative. The addition of immune checkpoint therapy to standard chemotherapy regimens has improved respons
Externí odkaz:
https://doaj.org/article/604f2ab58dbd40a8bc1286fd39a00ca8
Autor:
Scott A. Fisher, Kimberley Patrick, Tracy Hoang, Elly Marcq, Kiarash Behrouzfar, Sylvia Young, Timothy J. Miller, Bruce W. S. Robinson, Raphael Bueno, Anna K. Nowak, W. Joost Lesterhuis, Grant Morahan, Richard A. Lake
Publikováno v:
Frontiers in Toxicology, Vol 6 (2024)
Objectives: This study combines two innovative mouse models in a major gene discovery project to assess the influence of host genetics on asbestos related disease (ARD). Conventional genetics studies provided evidence that some susceptibility to meso
Externí odkaz:
https://doaj.org/article/3d44dba5e34544bab7bb7980e494ea5c
Publikováno v:
Amstat News. Apr2020, Issue 514, p21-23. 3p.
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Chemotherapy has historically been the mainstay of cancer treatment, but our understanding of what drives a successful therapeutic response remains limited. The diverse response of cancer patients to chemotherapy has been attributed principally to di
Externí odkaz:
https://doaj.org/article/e6d00f5ca20546b5b9b062d82fa200d8
Publikováno v:
The Irish Naturalists' Journal, 1954 Apr 01. 11(6), 179-179.
Externí odkaz:
https://www.jstor.org/stable/25534214
Autor:
Nicola Principe, Wayne J. Aston, Danika E. Hope, Caitlin M. Tilsed, Scott A. Fisher, Louis Boon, Ian M. Dick, Wee Loong Chin, Alison M. McDonnell, Anna K. Nowak, Richard A. Lake, Jonathan Chee, Willem Joost Lesterhuis
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Antibodies that target immune checkpoints such as cytotoxic T lymphocyte antigen 4 (CTLA‐4) and the programmed cell death protein 1/ligand 1 (PD-1/PD-L1) are now a treatment option for multiple cancer types. However, as a monotherapy, objective res
Externí odkaz:
https://doaj.org/article/eebc1cc11d8240f49cafed6001ba43c0
Autor:
Scott A. Fisher, Carolyn J. Peddle-McIntyre, Kimberley Burton, Robert U. Newton, Elly Marcq, Richard A. Lake, Anna K. Nowak
Publikováno v:
BMC Research Notes, Vol 13, Iss 1, Pp 1-8 (2020)
Abstract Objective There is substantial evidence that exercise can safely reduce the risk of cancer and improve survival in different human cancer populations. Long latency periods associated with carcinogen–induced cancers like asbestos induced me
Externí odkaz:
https://doaj.org/article/d11f9550bc764e9584fb4a8af38d4896
Autor:
Kiarash Behrouzfar, Kimberley Burton, Steve E. Mutsaers, Grant Morahan, Richard A. Lake, Scott A. Fisher
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Thoracic cancers pose a significant global health burden. Immune checkpoint blockade therapies have improved treatment outcomes, but durable responses remain limited. Understanding how the host immune system interacts with a developing tumor is essen
Externí odkaz:
https://doaj.org/article/a82081bb8d03424fbee6db218af0ec59
Autor:
Nicola Principe, Joel Kidman, Siting Goh, Caitlin M. Tilsed, Scott A. Fisher, Vanessa S. Fear, Catherine A. Forbes, Rachael M. Zemek, Abha Chopra, Mark Watson, Ian M. Dick, Louis Boon, Robert A. Holt, Richard A. Lake, Anna K. Nowak, Willem Joost Lesterhuis, Alison M. McDonnell, Jonathan Chee
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Immune checkpoint therapy (ICT) results in durable responses in individuals with some cancers, but not all patients respond to treatment. ICT improves CD8+ cytotoxic T lymphocyte (CTL) function, but changes in tumor antigen-specific CTLs post-ICT tha
Externí odkaz:
https://doaj.org/article/14028b32db2541389131a67ac973ccfb